GlassScriptPhysician profile
Kevin Bordeau
NPI 1164421509
$3,159.37
in general payments reported to CMS, 2019-2025
24 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $371 · 2021: $301 · 2022: $519 · 2023: $470 · 2024: $264 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,093.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,093.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $759.01 | 2019-2025 | Botox, Lupron Depot |
| Astellas Pharma US INC | $735.83 | 2019-2022 | |
| Pfizer INC. | $499.38 | 2019-2025 | |
| Boston Scientific Corporation | $207.91 | 2019-2023 | Ams Ambicor |
| Janssen Biotech, INC. | $181.89 | 2019-2020 | |
| Myovant Sciences INC. | $133.73 | 2021-2022 | |
| Ethicon US, LLC | $83.48 | 2022-2023 | Surgicel Nu-Knit, Ethicon |
| Dornier Medtech America, INC | $76.42 | 2023 | Dornier Medtech |
| Ferring Pharmaceuticals INC. | $66.53 | 2019-2025 | Adstiladrin |
| Calyxo, INC. | $51.11 | 2025 | Cvac Aspiration System |
| Axonics, INC. | $48.71 | 2023 | Axonics |
| Sumitomo Pharma America, INC. | $33.25 | 2023-2025 | Gemtesa, Orgovyx |
| Bioprotect Medical, INC. | $32.58 | 2025 | Bioprotect Balloon Implant System |
| C. R. Bard, INC. & Subsidiaries | $30.15 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.41 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $29.10 | 2025 | Xiaflex |
| Si-Bone, INC. | $28.29 | 2022 | |
| Avadel Specialty Pharmaceuticals, LLC | $26.12 | 2019 | |
| Olympus America INC. | $24.30 | 2020 | |
| Tolmar, INC. | $22.10 | 2025 | Eligard, Jatenzo |
| Urovant Sciences INC | $19.36 | 2022 | |
| Dentsply Ih INC. | $16.14 | 2019 | |
| Coloplast Corp | $12.47 | 2020 | |
| Endo Pharmaceuticals INC. | $12.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Bordeau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.